Others need a therapy that aligns with heart failure, kidney disease, or weight-related priorities
It works centrally by: Reducing appetite through effects on brain regions that regulate hunger and satiety Slowing gastric emptying , which promotes feelings of fullness after meals Improving glucose metabolism , though at the 3mg dose it is licensed specifically for weight management rather than diabetes treatment Patients typically experience reduced food cravings and earlier satiety, making it easier to adhere to a reduced-calorie diet
These medications act on the brain to reduce appetite signals and slow gastric emptying, so that people feel fuller with less food and for longer, which may support reductions in body fat over time, she explains
Semaglutide Vs Tirzepatide: Which Is Better
This benefit comes at higher lifetime cost ($131,686 vs $87,082), yielding an incremental cost-effectiveness ratio (ICER) of $70,297 per QALY, below the U.S